Understanding how bacteria remember and fight infections
Generation of DNA memory by bacterial CRISPR-Cas9 systems
This study is looking at how certain bacteria, like Neisseria meningitidis, use a special system to remember and fight off infections, which could help us find better ways to treat bacterial infections and tackle antibiotic resistance.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10894133 on NIH RePORTER |
What this research studies
This research investigates how bacteria use a system called CRISPR-Cas9 to remember and defend against infections caused by harmful genetic elements. By studying the gram-negative pathogen Neisseria meningitidis, the research aims to uncover the mechanisms behind how bacteria acquire and store these immunological memories. This knowledge could lead to new strategies for combating antibiotic resistance and improving treatments for bacterial infections. The approach involves detailed genetic analysis and experimentation to understand the molecular processes involved in CRISPR memory formation.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals affected by antibiotic-resistant bacterial infections.
Not a fit: Patients with viral infections or those not affected by antibiotic resistance may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative methods for preventing and treating antibiotic-resistant infections.
How similar studies have performed: Other research has shown promise in understanding CRISPR systems, but this specific approach to studying memory formation in Neisseria meningitidis is relatively novel.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Zhang, Yan — University of Michigan at Ann Arbor
- Study coordinator: Zhang, Yan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.